Principles of Antimicrobial Use in Older Adults

Clinics in Geriatric Medicine

Volumn 23, Issue 3, 2007, Pages 481-497

  Herring, Ashley R ^a   Williamson, John C ^a  

^a WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ATORVASTATIN; CEFUROXIME; CLARITHROMYCIN; COTRIMOXAZOLE; DIGOXIN; ERYTHROMYCIN; FLUCONAZOLE; GLIPIZIDE; GRISEOFULVIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISONIAZID; ITRACONAZOLE; KETOCONAZOLE; METRONIDAZOLE; MEVINOLIN; NAFCILLIN; PHENYTOIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SIMVASTATIN; STOMACH SECRETION INHIBITOR; TELITHROMYCIN; TETRACYCLINE DERIVATIVE; UNINDEXED DRUG; VORICONAZOLE; WARFARIN;

ADULT; AGED; ANTIMICROBIAL THERAPY; BLEEDING; COMORBIDITY; DRUG CROSS REACTIVITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; ELDERLY CARE; HEART ARRHYTHMIA; HUMAN; INFECTION; LIFESTYLE; LIVER TOXICITY; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NEPHROTOXICITY; OTOTOXICITY; OUTCOMES RESEARCH; PRACTICE GUIDELINE; QT PROLONGATION; REVIEW; TORSADE DES POINTES; VANCOMYCIN RESISTANT ENTEROCOCCUS;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; HUMANS; PRACTICE GUIDELINES; TREATMENT OUTCOME;

EID: 34447275264     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cger.2007.03.009     Document Type: Review

References (61)

1. Meehan T.P., Fine M.J., Krumholz H.M., et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 278 (1997) 2080-2084
2. Houck P.M., Bratzler D.W., Nsa W., et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 164 (2004) 637-644
3. Luna C.M., Aruj P., Niederman N.S., et al. Appropriateness and delay to initiate therapy in ventilator-associated pneumonia. Eur Respir J 27 (2006) 158-164
4. Iregui M., Ward S., Sherman G., et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 122 (2002) 262-268
5. Valles J., Rello J., Ochagavia A., et al. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest 123 (2003) 1615-1624
6. Kang C.I., Kim S.H., Park W.G., et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 49 (2005) 760-766
7. Frei C.R., Restrepo M.I., Mortensen E.M., et al. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia. Am J Med 119 (2006) 865-871
8. Mortensen E.M., Restrepo M., Anzueto A., et al. Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia. Am J Med 117 (2004) 726-731
9. Soo Hoo G.W., Wen Y.E., Nguyen T.V., et al. Impact of clinical guidelines in the management of severe hospital-acquired pneumonia. Chest 128 (2005) 2778-2787
10. Fraser A., Paul M., Almanasreh N., et al. Benefit of appropriate empirical antibiotic treatment: thirty-day mortality and duration of hospital stay. Am J Med 119 (2006) 970-976
11. Ibrahim E.H., Sherman G., Ward S., et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118 (2000) 146-155
12. Schramm G.E., Johnson J.A., Doherty J.A., et al. Methicillin-resistant Staphylococcus aureus sterile-site infection: the importance of appropriate initial antimicrobial treatment. Crit Care Med 34 (2006) 2069-2074
13. MacArthur R.D., Miller M., Albertson T., et al. Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS Trial. Clin Infect Dis 38 (2004) 284-288
14. Ibrahim E.H., Ward S., Sherman G., et al. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 21 (2001) 1109-1115
15. Beardsley J.R., Williamson J.C., Johnson J.W., et al. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. Chest 130 (2006) 787-793
16. Singh N., Rogers P., Atwood C.W., et al. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. Am J Respir Crit Care Med 162 (2000) 505-511
17. ATS Board of Directors and IDSA Guideline Committee. Guidelines for the management of adults with hospital-acquired, ventilator-associated and healthcare-associated pneumonia. Am J Respir Crit Care Med 171 (2005) 388-416
18. Mandell L.A., Bartlett J.G., Dowell S.F., et al. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 37 11 (2003) 1405-1433
19. Bentley D.W., Bradley S., High K., et al. Practice guideline for evaluation of fever and infection in long-term care facilities. Clin Infect Dis 31 (2000) 640-653
20. Roghmann M.C., Warner J., and Mackowiak P.A. The relationship between age and fever magnitude. Am J Med Sci 322 (2001) 68-70
21. Castle S.C., Yeh M., Toledo S., et al. Lowering the temperature criterion improves detection of infections in nursing home residents. Aging Immunol Infect Dis 4 (1993) 67-76
22. Norman D.C., and Yoshikawa T.T. Fever in the elderly. Infect Dis Clin North Am 10 (1996) 93-99
23. Wasserman M., Levinstein M., Keller E., et al. Utility of fever, white blood cells, and differential count in predicting bacterial infections in the elderly. J Am Geriatr Soc 37 (1989) 537-543
24. Loo V.G., Poirier L., Miller M.A., et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353 (2005) 2442-2449
25. Pepin J., Valiquette L., Alary M.E., et al. Clostridium difficile associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 171 (2004) 466-472
26. Thompson W.W., Shay D.K., Weintraub E., et al. Influenza-associated hospitalizations in the United States. JAMA 292 (2004) 1333-1340
27. Thompson W.W., Shay D.K., Weintraub E., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289 (2003) 179-186
28. Hoyert D.L., Heron M.P., Murphy S.L., et al. Deaths: final data for 2003. Natl Vital Stat Rep 54 (2006) 1-120
29. Kirby J.T., Fritsche T.R., and Jones R.N. Influence of patient age on the frequency of occurrence and antimicrobial resistance patterns of isolates from hematology/oncology patients: report from the Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance Program (North America). Diagn Microbiol Infect Dis 56 (2006) 75-82
30. Hurwitz A., Ruhl C.E., Kimler B.F., et al. Gastric function in the elderly: effects on absorption of ketoconazole. J Clin Pharmacol 43 (2003) 996-1002
31. Feldman M., Cryer B., McArthur K.E., et al. Effects of aging and gastritis on gastric acid and pepsin secretion in humans: a prospective study. Gastroenterology 110 (1996) 1043-1052
32. Marangos M.N., Skoutelis A.T., Nightingale C.H., et al. Absorption of ciprofloxacin in patients with diabetic gastroparesis. Antimicrob Agents Chemother 39 (1995) 2161-2163
33. Beyth R.J., and Shorr R.I. Medication use. In: Duthie E.H., and Katz P.R. (Eds). Practice of geriatrics. 3rd edition (1998), W.B. Saunders, Philadelphia 38-47
34. Vestal R.E. Aging and pharmacology. Cancer 80 (1977) 1302-1310
35. Turnheim K. Drug dosage in the elderly: Is it rational?. Drugs Aging 13 (1998) 357-379
36. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
37. Cirillo M., Anastasio P., and De Santo N.G. Relationship of gender, age, and body mass index to errors in predicted kidney function. Nephrol Dial Transplant 20 (2005) 1791-1798
38. Drusano G.L., Munice H.L., Hoopes J.M., et al. Commonly used methods of estimating creatinine clearance are inadequate for elderly debilitated nursing home patients. J Am Geriatr Soc 36 (1988) 437-441
39. Smythe M., Hoffman J., Kizy K., et al. Estimating creatinine clearance in elderly patients with low serum creatinine concentrations. Am J Hosp Pharm 51 (1994) 198-204
40. Turnheim K. Drug therapy in the elderly. Exp Gerontol 39 (2004) 1731-1738
41. Drusano G.L., Preston S.L., Fowler C., et al. Relationship between fluoroquinolone area under the curve:minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia. J Infect Dis 189 (2004) 1590-1597
42. Schneitman-McIntire O., Farnen T.A., Gordon N., et al. Medication misadventures resulting in emergency department visits at an HMO medical center. Am J Hosp Pharm 53 (1996) 1416-1422
43. Evans R.S., Lloyd J.F., Stoddard G.J., et al. Risk factors for adverse drug events: a 10-year analysis. Ann Pharmacother 39 (2005) 1161-1168
44. Bates D.W., Miller E.B., Cullen D.J., et al. Patient risk factors for adverse drug events in hospitalized patients. Arch Intern Med 159 (1999) 2553-2559
45. Peyriere H., Cassan S., Floutard E., et al. Adverse drug events associated with hospital admission. Ann Pharmacother 37 (2003) 5-11
46. Baciewicz A.M., Sokos D.R., and Cowan R.I. Aminoglycoside-associated nephrotoxicity in the elderly. Ann Pharmacother 37 (2003) 182-186
47. Paterson D.L., Robson J.M., and Wagener M.M. Risk factors for toxicity in elderly patients given aminoglycosides once daily. J Gen Intern Med 13 (1998) 735-739
48. Baddour L.M., Wilson W.R., Bayer A.S., et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications. A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111 (2005) 394-434
49. Owens Jr. R.C., and Ambrose P.G. Antimicrobial safety: focus on fluoroquinolones. Clin Infect Dis 41 Suppl 2 (2005) S144-S157
50. Fountain F.F., Tolley E., Chrisman C.R., et al. Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection. Chest 128 (2005) 116-123
51. Fernandez-Villar A., Sopena B., Fernandez-Villar J., et al. The influence of risk factors on the severity of anti-tuberculosis drug-induced hepatotoxicity. Int J Tuberc Lung Dis 8 (2004) 1499-1505
52. Lucena M.I., Andrade R.J., Fernandez M.C., et al. Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from Spain. Hepatology 44 (2006) 850-856
53. Larrey D., Vial T., Pauwels A., et al. Hepatitis associated with amoxicillin-clavulanic acid combination: report of 15 cases. Gut 33 (1992) 368-371
54. Garcia Rodriguez L.A., Stricker B.H., and Zimmerman H.J. Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid. Arch Intern Med 156 (1996) 1327-1332
55. Kaufman D.W., Kelly J.P., Rosenberg L., et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone Survey. JAMA 287 (2002) 337-344
56. Ketek (telithromycin). [package insert] (2006), Sanofi-Aventis, Bridgewater (NJ)
57. Andriole V.T., Haverstock D.C., and Choudhri S.H. Retrospective analysis of the safety profile of oral moxifloxacin in elderly patients enrolled in clinical trials. Drug Saf 28 (2005) 443-452
58. Nicholson S.C., High K.P., Gothelf S., et al. Gatifloxacin in community-based treatment of acute respiratory tract infections in the elderly. Diagn Microbiol Infect Dis 44 (2002) 109-116
59. Yanagihara K., Fukuda Y., Seki M., et al. Clinical comparative study of sulbactam/ampicillin and imipenem/cilastatin in elderly patients with community-acquired pneumonia. Intern Med 45 (2006) 995-999
60. Kadowaki M., Demura Y., Mizuno S., et al. Reappraisal of clindamycin IV monotherapy for treatment of mild-to-moderate aspiration pneumonia in elderly patients. Chest 127 (2005) 1276-1282
61. El Moussaoui R., Opmeer B.C., de Borgie C.A., et al. Long-term symptom recovery and health-related quality of life in patients with mild-to-moderate-severe community-acquired pneumonia. Chest 130 (2006) 1165-1172